“It is imperative that GeNOsys brings its inexpensive portable new technology for generating Nitric Oxide gas to the bedside as quickly as possible to reduce the catastrophic effects tuberculosis has imposed on mankind.”
- Dr. Stephen D. Minton, M.D “GeNOsys has completed the scientific process and has successfully developed commercially viable Nitric Gas Generator technology as well as the proprietary formulization for its consumable Tablet Medium. Now is the time to leverage that science and those assets to monetize our products, take them to the market and generate sustainable and reoccurring revenue.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.